Remove 2025 Remove Cultivation Remove Extraction Remove Patients
article thumbnail

Avicanna Completes First Commercial Export of Aureus Branded Full Spectrum Psychoactive CBD Cannabis Extracts to Brazil

Cannabis Law Report

This initial export to Brazil marks Avicanna ’s first commercial export of psychoactive Cannabis Extracts into the emerging Brazilian medicinal cannabis market and the delivery of the initial purchase order from the previously announced three (3) year master supply agreement. and Santa Marta Golden Hemp S.A.S.,

article thumbnail

Curaleaf International Secures Complete GMP Certification of Second EU GMP Facility in Europe

Cannabis Law Report

Milestone for Medalchemy in Spain; facility now fully licensed to import, cultivate, extract, manufacture and export medical cannabis flower and extracts. billion by 2025. billion by 2025. Accelerates export capacity to serve growing European and international medical cannabis markets.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Curaleaf International Advances Accessibility of Medical Cannabis Products in Germany with Strategic Partnership

Cannabis Law Report

The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. billion 1 by 2025. “We are constantly seeking ways to enhance the life of chronically neurologically ill patients with our products. It is expected to be worth USD 2.1 About Zambon Spa.

Access 105
article thumbnail

A homegrown business: Medical cannabis firm Equinox set for a London IPO with an eye on ending Britain’s reliance on imports

Cannabis Law Report

Medical cannabis business Equinox International is planning to list on the London Stock Exchange to raise cash for a ‘state-of-the-art’ cultivation, extraction and production facility on a Home Office-approved 20-acre UK site. UK medical cannabis market to have addressable market of £7.5bn by 2028 . ’ Source: [link].

article thumbnail

Launch of Curaleaf International driven by the liberalisation of cannabis accelerating across Europe

Cannabis Law Report

billion by 2025 1. Curaleaf International’s cannabis flower products and extracted cannabis-based products now supply five separate markets, including Germany, Europe’s largest market for medicinal cannabis which is expected to be worth over €840 million by 2025 1. billion by 2025 1. billion by 2025 1.

article thumbnail

Flora Growth Closes Investment in Hoshi, Provides Clear Expected Pathway To European Distribution

Cannabis Law Report

NASDAQ: FLGC) (“Flora” or the “Company”), an all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced it has closed the previously announced € 2M (two-million Euros) investment in Hoshi International Inc. billion by 2025. billion by 2025. “We of the market. billion by 2028.

Events 105
article thumbnail

ABC News (Australia): Why is medical marijuana a high ranking priority for Thailand’s military?

Cannabis Law Report

It has approved use of cannabis extracts for treatment of a range of illnesses and conditions, including cancer, epilepsy, Alzheimer’s, Parkinson’s disease and anxiety. The Government has promised to open more clinics in greater Bangkok, with patients able to book appointments via a specialised smartphone app.